| Product Name | NebuSelect™ Recombinant Human LGR-5, hFc-tag |
|---|---|
| Catalog Number | NBL-241924 |
| Alias/Synonyms | LGR-5 |
| Appearance | see COA |
| Molecule Weight | Gly22-Pro543 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | O75473-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-241924-100ug | 100ug | Inquire | Inquire | |
| NBL-241924-1mg | 1mg | Inquire | Inquire | |
| NBL-241924-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human LGR-5, hFc-tag
Catalog#:
NBL-241924
Description:
NebuSelect™ Recombinant Human LGR-5, hFc-tag(Cat#NBL-241924) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Gly22-Pro543.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 85 kDa. Due to glycosylation, the protein migrates to 110-120 kDa based on Bis-Tris PAGE result.
Target Name:
LGR-5
Target Information:
G protein-coupled receptor 5 (LGR5), known as a stem cell marker for colon cancer and gastric cancer, can serve as a novel GSC marker involved in EMT and a therapeutic target in glioma.LGR5 is a new functional GSC marker and prognostic indicator that can promote EMT by activating the Wnt/β-catenin pathway and would thus be a novel therapeutic target for glioma.
Amino Acid Sequence:
Gly22-Pro543
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.